Every SEC Form 3/4/5 on record for this filer (CIK 1405692) — 6 issuers, 28 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| MXCT | MAXCYTE, INC. | Director | 2024-10-16 → 2026-06-22 | 4 | — |
| CDXS | CODEXIS, INC. | Director | 2025-04-01 → 2026-06-18 | 4 | — |
| CERT | Certara, Inc. | Director | 2021-08-02 → 2026-05-15 | 8 | — |
| PSTX | Poseida Therapeutics, Inc. | Director | 2021-07-26 → 2025-01-08 | 6 | — |
| DMTK | DermTech, Inc. | Director · lapsed | 2019-09-09 → 2023-06-05 | 7 | — |
| EDIT | Editas Medicine, Inc. | CEO · lapsed | 2018-12-10 → 2021-02-10 | 10 | −$290,688 |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
4 of 6 issuers are covered and open a security page; the rest are on file here only.